Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
暂无分享，去创建一个
H. Williams | J. A. Cook | S. Hider | L. Coates | J. Nguyen-Van-Tam | D. Altmann | R. Boyton | V. Barber | Á. McKnight | A. Layton | M. Lwin | C. Holroyd | S. Horton | T. Brooks | I. Rombach | T. Youngstein | V. Saravanan | A. Pratt | A. Hawarden | A. Abhishek | T. Batty | K. Gaffney | N. Gullick | S. Bingham | A. Valdes | A. Soni | N. Reynolds | Tomy Muringayil Joseph | L. Hunt | I. Pande | C. Rhys-Dillon | S. Venkatachalam | N. Peckham | J. Bluett | E. Price | A. Francis | L. Whittam | D. Walsh | S. Khalid | R. Ellis | P. Julier | L. Eldridge | A. Mustafa | L. Cureton | R. Crowder | N. Levell | Nicola Alcorn | Duncan E Appelbe | Ting Seng Tang | G. Tran | Gwenan Huws | R. Mathew | Stamatios Oikonomou | Catherine Gwynne | C. Tacu | E. George | A. Madan | A. Lapin | E. Lim | Mike Green | Alaa Hassan | Karen Douglas | Genevieve Ho | K. Levasseur | S. Treacy | M. Cheila | J. Pradeep | Catrin M Jones | J. Cook | H. Williams | John D. Pradeep | D. Appelbe | Agnieszka Lapin